Advertisement

Human Genetics

, Volume 128, Issue 1, pp 61–77 | Cite as

Update on molecular diagnosis of hereditary hemorrhagic telangiectasia

  • Jennifer Richards-Yutz
  • Kathleen Grant
  • Elizabeth C. Chao
  • Susan E. Walther
  • Arupa Ganguly
Original Investigation

Abstract

Hereditary hemorrhagic telangiectasia (HHT) is an autosomal dominant, vascular disease hallmarked by the development of arteriovenous malformations (AVMs). Germline mutations in two genes, endoglin (ENG) and activin receptor like kinase 1 (ACVRL1), have been implicated in this disease. This report describes molecular diagnosis in a consecutive series of 600 individuals with clinical features of HHT disease. Each coding exon and flanking intronic regions of ENG and ACVRL1 genes was sequenced. Exonic copy number was quantified in probands without a coding sequence mutation. Novel nonsynonymous variants were further analyzed to predict functional consequences. In addition, common single nucleotide polymorphisms genotypes and haplotypes for the two genes were compared between individuals with and without mutations. The highest mutation detection rate (87% [95% CI 80.2–91.5]) was observed in probands who met all four Curacao criteria (epistaxis, telangiectases, AVMs and family history). More than 30% of identified mutations were novel; however, only 6% were variants of unknown significance. Determining the significance of novel mutations as related to disease presents additional challenges. Detection of multiple alterations in the same proband also requires careful evaluation for disease association. In conclusion, the sensitivity of molecular diagnosis is highest in probands with a clinically confirmed diagnosis of HHT. However, a substantial fraction of probands in this group do not carry an identifiable mutation in the coding exons of these two genes. This suggests alternate mechanisms of gene inactivation or involvement of alternate loci, and it requires further investigation.

Keywords

Single Nucleotide Polymorphism Molecular Diagnosis Hereditary Hemorrhagic Telangiectasia Nonsynonymous Change Telangiectasis 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Notes

Acknowledgments

The authors are grateful to all physicians submitting requests for molecular diagnosis of HHT. The authors are especially indebted to Kristina Bisacquino and Laurie Brenner for analysis of familial mutations and their respective segregations in pedigrees, and also, Andrew Walther for help with data entry for individual genotypes into our HHT database.

References

  1. Abdalla SA, Geisthoff UW, Bonneau D, Plauchu H, McDonald J, Kennedy S, Faughnan ME, Letarte M (2003) Visceral manifestations in hereditary haemorrhagic telangiectasia type 2. J Med Genet 40:494–502CrossRefPubMedGoogle Scholar
  2. Abdalla SA, Cymerman U, Rushlow D, Chen N, Stoeber GP, Lemire EG, Letarte M (2005) Novel mutations and polymorphisms in genes causing hereditary hemorrhagic telangiectasia. Hum Mutat 25:320–321CrossRefPubMedGoogle Scholar
  3. Barrett JC, Fry B, Maller J, Daly MJ (2005) Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 21:263–265CrossRefPubMedGoogle Scholar
  4. Bayrak-Toydemir P, McDonald J, Akarsu N, Toydemir RM, Calderon F, Tuncali T, Tang W, Miller F, Mao R (2006) A fourth locus for hereditary hemorrhagic telangiectasia maps to chromosome 7. Am J Med Genet A 140:2155–2162PubMedGoogle Scholar
  5. Bayrak-Toydemir P, McDonald J, Mao R, Phansalkar A, Gedge F, Robles J, Goldgar D, Lyon E (2008) Likelihood ratios to assess genetic evidence for clinical significance of uncertain variants: hereditary hemorrhagic telangiectasia as a model. Exp Mol Pathol 85:45–49CrossRefPubMedGoogle Scholar
  6. Berg J, Porteous M, Reinhardt D, Gallione C, Holloway S, Umasunthar T, Lux A, McKinnon W, Marchuk D, Guttmacher A (2003) Hereditary haemorrhagic telangiectasia: a questionnaire based study to delineate the different phenotypes caused by endoglin and ALK1 mutations. J Med Genet 40:585–590CrossRefPubMedGoogle Scholar
  7. Bossler AD, Richards J, George C, Godmilow L, Ganguly A (2006) Novel mutations in ENG and ACVRL1 identified in a series of 200 individuals undergoing clinical genetic testing for hereditary hemorrhagic telangiectasia (HHT): correlation of genotype with phenotype. Hum Mutat 27:667–675CrossRefPubMedGoogle Scholar
  8. Bourdeau A, Dumont DJ, Letarte M (1999) A murine model of hereditary hemorrhagic telangiectasia. J Clin Invest 104:1343–1351CrossRefPubMedGoogle Scholar
  9. Cartegni L, Wang J, Zhu Z, Zhang MQ, Krainer AR (2003) ESEfinder: a web resource to identify exonic splicing enhancers. Nucleic Acids Res 31:3568–3571CrossRefPubMedGoogle Scholar
  10. Cole SG, Begbie ME, Wallace GM, Shovlin CL (2005) A new locus for hereditary haemorrhagic telangiectasia (HHT3) maps to chromosome 5. J Med Genet 42:577–582CrossRefPubMedGoogle Scholar
  11. Dakeishi M, Shioya T, Wada Y, Shindo T, Otaka K, Manabe M, Nozaki J, Inoue S, Koizumi A (2002) Genetic epidemiology of hereditary hemorrhagic telangiectasia in a local community in the northern part of Japan. Hum Mutat 19:140–148CrossRefPubMedGoogle Scholar
  12. Faughnan ME, Palda VA, Garcia-Tsao G, Geisthoff UW, McDonald J, Proctor DD, Spears J, Brown DH, Buscarini E, Chesnutt MS, Cottin V, Ganguly A, Gossage JR, Guttmacher AE, Hyland RH, Kennedy SJ, Korzenik J, Mager JJ, Ozanne AP, Piccirillo JF, Picus D, Plauchu H, Porteous ME, Pyeritz RE, Ross DA, Sabba C, Swanson K, Terry P, Wallace MC, Westermann CJ, White RI, Young LH, Zarrabeitia R (2009) International guidelines for the diagnosis and management of hereditary hemorrhagic telangiectasia. J Med GenetGoogle Scholar
  13. Fernandez LA, Sanz-Rodriguez F, Zarrabeitia R, Perez-Molino A, Morales C, Restrepo CM, Ramirez JR, Coto E, Lenato GM, Bernabeu C, Botella LM (2006) Mutation study of Spanish patients with hereditary hemorrhagic telangiectasia and expression analysis of endoglin and ALK1. Hum Mutat 27:295CrossRefGoogle Scholar
  14. Gallione CJ, Repetto GM, Legius E, Rustgi AK, Schelley SL, Tejpar S, Mitchell G, Drouin E, Westermann CJ, Marchuk DA (2004) A combined syndrome of juvenile polyposis and hereditary haemorrhagic telangiectasia associated with mutations in MADH4 (SMAD4). Lancet 363:852–859CrossRefPubMedGoogle Scholar
  15. Govani FS, Shovlin CL (2009) Hereditary haemorrhagic telangiectasia: a clinical and scientific review. Eur J Hum Genet 17:860–871CrossRefPubMedGoogle Scholar
  16. Guttmacher AE, Marchuk DA, White RI Jr (1995) Hereditary hemorrhagic telangiectasia. N Engl J Med 333:918–924CrossRefPubMedGoogle Scholar
  17. Kjeldsen AD, Vase P, Green A (1999) Hereditary haemorrhagic telangiectasia: a population-based study of prevalence and mortality in Danish patients. J Intern Med 245:31–39CrossRefPubMedGoogle Scholar
  18. Letteboer TG, Mager HJ, Snijder RJ, Lindhout D, Ploos van Amstel HK, Zanen P, Westermann KJ (2008) Genotype-phenotype relationship for localization and age distribution of telangiectases in hereditary hemorrhagic telangiectasia. Am J Med Genet A 146A:2733–2739CrossRefPubMedGoogle Scholar
  19. Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(−Delta Delta C(T)) method. Methods 25:402–408CrossRefPubMedGoogle Scholar
  20. McDonald J, Gedge F, Burdette A, Carlisle J, Bukjiok CJ, Fox M, Bayrak-Toydemir P (2009) Multiple sequence variants in hereditary hemorrhagic telangiectasia cases: illustration of complexity in molecular diagnostic interpretation. J Mol Diagn 11:569–575CrossRefPubMedGoogle Scholar
  21. Ng PC, Henikoff S (2003) SIFT: predicting amino acid changes that affect protein function. Nucleic Acids Res 31:3812–3814CrossRefPubMedGoogle Scholar
  22. Olivieri C, Pagella F, Semino L, Lanzarini L, Valacca C, Pilotto A, Corno S, Scappaticci S, Manfredi G, Buscarini E, Danesino C (2007) Analysis of ENG and ACVRL1 genes in 137 HHT Italian families identifies 76 different mutations (24 novel). Comparison with other European studies. J Hum Genet 52:820–829CrossRefPubMedGoogle Scholar
  23. Pece-Barbara N, Cymerman U, Vera S, Marchuk DA, Letarte M (1999) Expression analysis of four endoglin missense mutations suggests that haploinsufficiency is the predominant mechanism for hereditary hemorrhagic telangiectasia type 1. Hum Mol Genet 8:2171–2181CrossRefPubMedGoogle Scholar
  24. Plummer NW, Zawistowski JS, Marchuk DA (2005) Genetics of cerebral cavernous malformations. Curr Neurol Neurosci Rep 5:391–396CrossRefPubMedGoogle Scholar
  25. Ramensky V, Bork P, Sunyaev S (2002) Human non-synonymous SNPs: server and survey. Nucleic Acids Res 30:3894–3900CrossRefPubMedGoogle Scholar
  26. Sabba C, Pasculli G, Lenato GM, Suppressa P, Lastella P, Memeo M, Dicuonzo F, Guant G (2007) Hereditary hemorrhagic telangiectasia: clinical features in ENG and ALK1 mutation carriers. J Thromb Haemost 5:1149–1157CrossRefPubMedGoogle Scholar
  27. Shovlin CL (1999) Supermodels and disease: insights from the HHT mice. J Clin Invest 104:1335–1336CrossRefPubMedGoogle Scholar
  28. Shovlin CL, Guttmacher AE, Buscarini E, Faughnan ME, Hyland RH, Westermann CJ, Kjeldsen AD, Plauchu H (2000) Diagnostic criteria for hereditary hemorrhagic telangiectasia (Rendu-Osler-Weber syndrome). Am J Med Genet 91:66–67CrossRefPubMedGoogle Scholar
  29. Tchernitchko D, Goossens M, Wajcman H (2004) In silico prediction of the deleterious effect of a mutation: proceed with caution in clinical genetics. Clin Chem 50:1974–1978CrossRefPubMedGoogle Scholar
  30. Urness LD, Sorensen LK, Li DY (2000) Arteriovenous malformations in mice lacking activin receptor-like kinase-1. Nat Genet 26:328–331CrossRefPubMedGoogle Scholar
  31. Valle L, Serena-Acedo T, Liyanarachchi S, Hampel H, Comeras I, Li Z, Zeng Q, Zhang HT, Pennison MJ, Sadim M, Pasche B, Tanner SM, de la Chapelle A (2008) Germline allele-specific expression of TGFBR1 confers an increased risk of colorectal cancer. Science 321:1361–1365CrossRefPubMedGoogle Scholar
  32. Weksberg R, Hughes S, Moldovan L, Bassett AS, Chow EW, Squire JA (2005) A method for accurate detection of genomic microdeletions using real-time quantitative PCR. BMC Genomics 6:180CrossRefPubMedGoogle Scholar
  33. Wooderchak W, Bukjiok CJ, Damjanovich K, Lewis T, Gedge F, McDonald J, Bayrak-Toydemir P (2009) Linkage and candidate gene analysis of four large HHT families. American Society of Human Genetics, Program #2847; Poster #787Google Scholar

Copyright information

© Springer-Verlag 2010

Authors and Affiliations

  • Jennifer Richards-Yutz
    • 1
  • Kathleen Grant
    • 1
  • Elizabeth C. Chao
    • 1
  • Susan E. Walther
    • 1
  • Arupa Ganguly
    • 1
  1. 1.Genetic Diagnostic Laboratory, Department of Genetics, School of MedicineUniversity of PennsylvaniaPhiladelphiaUSA

Personalised recommendations